The PRISM intervention, which focuses on stress management and resilience building for adolescents with type 1 diabetes (T1D), did not significantly affect HbA1c levels at 6 or 12 months but did ...
Merck's investigational RSV prophylactic monoclonal antibody, clesrovimab, designed to protect infants from respiratory syncytial virus (RSV) disease during their first RSV season, demonstrated ...
Octavio Ramilo, MD, joins us to discuss new clesrovimab phase 2b/3 study data presented at IDWeek 2024 in Los Angeles, California. In this Contemporary Pediatrics video interview, Octavio Ramilo, MD, ...
Contemporary Pediatrics was joined by Melissa Fickey, MD, a board-certified child, adolescent, and adult psychiatrist at Embracing Life Wellness Center in Riverview, Florida, to discuss transcranial ...
The approved indication is for patients aged 7 years and up with narcolepsy to treat cataplexy or excessive daytime sleepiness. The FDA has approved sodium oxybate (Lumryz; Avadel Pharmaceuticals) ...
"The magnitude of benefit, trajectory of symptomatic improvement, and dependency on the number of treatment sessions showed a treatment effect similar to that found in adults," stated study authors.
In a recent study, a decrease in opioid dispensing was observed among youths undergoing surgical procedures, but rates remained high enough to warrant additional action. Surgery occurs in ...
A full-term, healthy boy of African American ancestry was delivered via spontaneous vaginal delivery without any complications. The 36-year-old mother had a significant medical history of gestational ...
GLP-1 receptor agonists are increasingly being used to treat obesity in adolescents. According to the study investigators, Liya Kerem, MD, MSc, and Joshua Stokar, MD, GLP-1s have been increasingly ...
The ongoing challenges of mental health, artificial intelligence, and the addressing of social determinants of health are key themes of pediatric health care are topics of discussion with Matthew ...
According to the CDC, more than 44,900 people died from influenza complications during the 2023-2024 flu season. As it does every year, the CDC recommends everyone 6 months or older receive the ...
Brittany Bruggeman, MD, emphasizes that many patients with type 1 diabetes are unaware of the availability of advanced technologies like CGMs and automated insulin delivery systems. Brittany Bruggeman ...